Tanvir Ahmed
Department of Midwifery, Cumilla State Family Clinics, Cumilla, Bangladesh

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

First Trimester Ultrasound Biomarkers for Predicting Preeclampsia: A Prospective Cohort Study in Surabaya, Indonesia Reisha Notonegoro; Aline Hafidzah; Reza Andrianto; Tanvir Ahmed
Sriwijaya Journal of Obstetrics and Gynecology Vol. 3 No. 1 (2025): Sriwijaya Journal of Obstetrics and Gynecology
Publisher : Phlox Institute: Indonesian Medical Research Organization

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59345/sjog.v2i2.180

Abstract

Introduction: Preeclampsia (PE) remains a leading cause of maternal and perinatal morbidity and mortality worldwide, particularly in developing countries like Indonesia. Early identification of high-risk women is crucial for timely intervention. This study aimed to evaluate the predictive performance of first-trimester ultrasound biomarkers, specifically uterine artery pulsatility index (UtA-PI) and mean arterial pressure (MAP), combined with maternal characteristics, for predicting PE in a cohort of pregnant women in Surabaya, Indonesia. Methods: This prospective cohort study enrolled pregnant women attending their first-trimester antenatal care visit at Private Hospital, Surabaya, between January 2022 and December 2023. Inclusion criteria were singleton pregnancies, gestational age between 11 and 13 weeks 6 days, and availability of complete follow-up data until delivery. Maternal characteristics (age, body mass index, parity, smoking history, family history of PE) were recorded. UtA-PI was measured using transabdominal Doppler ultrasound, and MAP was calculated from blood pressure measurements. The primary outcome was the development of PE, defined according to the International Society for the Study of Hypertension in Pregnancy (ISSHP) criteria. Logistic regression analysis was used to develop a prediction model, and its performance was assessed using receiver operating characteristic (ROC) curves and area under the curve (AUC). Results: A total of 850 pregnant women were included in the final analysis. The incidence of PE was 8.2% (n=70). The prediction model incorporating maternal age, BMI, prior history of PE, UtA-PI, and MAP demonstrated good predictive performance for overall PE (AUC = 0.85; 95% CI, 0.81-0.89). For early-onset PE (delivery <34 weeks), the AUC was 0.92 (95% CI, 0.87-0.97), and for late-onset PE (delivery ≥34 weeks), the AUC was 0.78 (95% CI, 0.73-0.83). UtA-PI and MAP were significant independent predictors of PE (p<0.001). A risk score was developed, with a cut-off value showing a sensitivity of 80% and specificity of 75% for overall PE. Conclusion: The combination of maternal characteristics, UtA-PI, and MAP in the first trimester provides a valuable tool for predicting PE in an Indonesian population. This model demonstrates particularly strong performance for predicting early-onset PE, which is associated with greater maternal and fetal morbidity. Early identification of high-risk women allows for targeted surveillance and potential preventative strategies.
Admission interleukin-6 and carbapenemase carriage independently predict 30-day mortality in female Fournier's gangrene: a multicenter cohort Rini Kuswohadi Pramono; Tanvir Ahmed; Annisa
Sriwijaya Journal of Obstetrics and Gynecology Vol. 4 No. 1 (2026): Sriwijaya Journal of Obstetrics & Gynecology
Publisher : Phlox Institute: Indonesian Medical Research Organization

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59345/sjog.v4i1.304

Abstract

Background: Female Fournier's gangrene (FG) is an underrecognized obstetric and gynecologic infectious emergency that frequently arises from vulvar, Bartholin gland, and episiotomy-related sources and carries high mortality. Rising multidrug resistance threatens standard empirical antibiotic regimens, yet female-specific data integrating inflammatory biomarkers with the genomic resistome are scarce. Objective: To identify independent predictors of 30-day mortality and characterize the genomic resistome in women with FG to inform targeted broad-spectrum therapy. Methods: In this multicenter retrospective cohort at two tertiary referral hospitals in Palembang, Indonesia (January 2020–December 2025), 42 women with surgically confirmed FG were studied. Admission interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), procalcitonin (PCT), and C-reactive protein (CRP) were measured; deep-tissue isolates underwent culture, broth-microdilution MIC testing, and multiplex PCR/next-generation sequencing for resistance genes. Multivariable logistic regression, ROC analysis, and Kaplan-Meier/Cox modeling were performed. Results: Thirty-day mortality was 26.2% (95% CI 15.3–41.1), and infections were polymicrobial in 85.7%. Non-survivors had markedly higher admission IL-6 (485.2 vs 142.5 pg/mL; p<0.001; Cohen's d=2.58) and PCT (18.6 vs 4.2 ng/mL; p<0.001). IL-6 predicted mortality with an AUC of 0.93 (95% CI 0.83–0.99), outperforming LRINEC (AUC 0.69). Independent predictors were carbapenemase-producing isolates (adjusted OR 4.15, 95% CI 1.85–9.20; p=0.001) and admission IL-6 ≥300 pg/mL (adjusted OR 3.80, 95% CI 1.62–8.85; p=0.002). Resistome-concordant empirical therapy was associated with lower mortality (modeled NNT 3). Conclusion: Admission IL-6 and carbapenemase carriage independently predicted 30-day mortality in this female FG cohort. Rapid biomarker and resistome screening may support risk stratification and empirical coverage in high-resistance tertiary settings, but prospective external validation is required before practice adoption.